Ulcerative colitis: Rescue immune suppression for severe colitis--worth the risk?

Nat Rev Gastroenterol Hepatol. 2011 Jun;8(6):303-4. doi: 10.1038/nrgastro.2011.86.
No abstract available

Publication types

  • Comment
  • News

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Colitis, Ulcerative / drug therapy*
  • Cyclosporine / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Recurrence
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Cyclosporine
  • Infliximab